Document is current
Any future updates will be listed below
-
Authors
Bashir, Salam
Fezeu, Leopold K.
Leviatan Ben-Arye, Shani
Yehuda, Sharon
Reuven, Eliran Moshe
Szabo de Edelenyi, Fabien
Fellah-Hebia, Imen
Le Tourneau, Thierry
Imbert-Marcille, Berthe Marie
Drouet, Emmanuel B.
Touvier, Mathilde
Roussel, Jean-Christian
Yu, Hai
Chen, Xi
Hercberg, Serge
Cozzi, Emanuele
Soulillou, Jean-Paul
Galan, Pilar
Padler-Karavani, Vered https://orcid.org/0000-0002-4761-3571
-
Funding
Funding for this research was provided by:
H2020 European Research Council (ERC-2016-STG-716220)
Ministère de la Santé, Santé Publique France, Institut National de la Santé et de la Recherche Médicale
Institut National de la Recherche Agronomique
Conservatoire National des Arts et Métiers (CNAM) and Université Paris 13
- License Information
-
More Information
Article History
Received: 1 May 2020
Accepted: 27 July 2020
First Online: 23 September 2020
Ethics approval and consent to participate
: The NutriNet-Santé was approved by the ethics committee of the French Institute for Health and Medical Research (IRB Inserm no. 0000388FWA00005831) and by the National Commission on Informatics and Liberty (CNIL no. 908450 and no. 909216). Electronic informed consent was obtained from each participant. Samples were used in accordance with the Helsinki Declaration and Tel Aviv University Institutional Review Board.
: Not applicable.
: V.P-K., S.B., L.K.F., and P.G. declare the following competing financial interest: Results of this work are part of a patent application filed by Tel Aviv University. J-P.S. is the founder of Xenothera, à French start-up dedicated to Neu5Gc knockout pig products, and collaborate with Avantea, a company with which they have produced Neu5Gc knockout cows. All other authors declare that no financial or non-financial competing interests exist.
